Document is current
Any future updates will be listed below
-
Authors
Kiviaho, Antti https://orcid.org/0000-0001-7419-0773
Eerola, Sini K.
Kallio, Heini M. L. https://orcid.org/0000-0003-4345-1787
Andersen, Maria K. https://orcid.org/0000-0003-2883-2450
Hoikka, Miina https://orcid.org/0009-0009-7052-9974
Tiihonen, Aliisa M. https://orcid.org/0000-0003-3703-9673
Salonen, Iida https://orcid.org/0009-0006-3176-7265
Spotbeen, Xander
Giesen, Alexander https://orcid.org/0000-0002-3345-4573
Parker, Charles T. A.
Taavitsainen, Sinja https://orcid.org/0000-0001-7559-9853
Hantula, Olli
Marttinen, Mikael
Hermelo, Ismaïl
Ismail, Mazlina https://orcid.org/0000-0002-1514-3819
Midtbust, Elise
Wess, Maximilian https://orcid.org/0009-0002-4227-6569
Devlies, Wout https://orcid.org/0000-0003-0725-6300
Sharma, Abhibhav https://orcid.org/0000-0001-5513-6210
Krossa, Sebastian https://orcid.org/0000-0002-1959-0130
Häkkinen, Tomi
Afyounian, Ebrahim https://orcid.org/0000-0002-0755-0131
Vandereyken, Katy
Kint, Sam https://orcid.org/0000-0002-6719-2903
Kesseli, Juha https://orcid.org/0000-0001-5812-3191
Tolonen, Teemu https://orcid.org/0000-0003-2029-6497
Tammela, Teuvo L. J.
Viset, Trond
Størkersen, Øystein
Giskeødegård, Guro F. https://orcid.org/0000-0003-2157-8824
Rye, Morten B.
Murtola, Teemu
Erickson, Andrew
Latonen, Leena https://orcid.org/0000-0003-4502-2193
Bova, G. Steven https://orcid.org/0000-0003-1639-3104
Mills, Ian G.
Joniau, Steven https://orcid.org/0000-0003-3195-9890
Swinnen, Johannes V. https://orcid.org/0000-0002-7720-5077
Voet, Thierry https://orcid.org/0000-0003-1204-9963
Mirtti, Tuomas
Attard, Gerhardt https://orcid.org/0000-0002-4811-7983
Claessens, Frank https://orcid.org/0000-0002-8676-7709
Visakorpi, Tapio
Rautajoki, Kirsi J. https://orcid.org/0000-0001-6549-7810
Tessem, May-Britt https://orcid.org/0000-0001-5734-2157
Urbanucci, Alfonso https://orcid.org/0000-0003-2931-3652
Nykter, Matti https://orcid.org/0000-0001-6956-2843
-
Funding
Funding for this research was provided by:
Syöpäsäätiö
Academy of Finland (312043)
- License Information
-
More Information
Article History
Received: 3 June 2024
Accepted: 8 November 2024
First Online: 16 November 2024
Change Date: 22 April 2025
Change Type: Update
Change Details: In the Acknowledgements section, the Norwegian Cancer Society project no. 333723-2023 should have read project no. 273672-2023. The original article has been corrected.
Competing interests
: C.T.A.P.’s employer may gain commercially from licensing data to Artera AI. G.A. received personal fees, grants, and travel support from Janssen and Astellas Pharma; personal fees or travel support from Pfizer, Novartis/AAA, Bayer Healthcare Pharmaceuticals, AstraZeneca, and Sanofi-Aventis; in addition, G.A.’s former employer, The Institute of Cancer Research, receives royalty income from abiraterone and G.A. receives a share of this income through the Institute’s Rewards to Discoverers Scheme. G.A. has received research funding (institutional) from Janssen, Astellas Pharma, and Novartis. All other authors declare no potential conflicts of interest.
